On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

This tool helps to analyze the MySQL/MariaDB binary log files. The generated report will give an overview of how many UPDATE, INSERT, DELETE, DROP and TRUNCATE operations appear in the binary logs.

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. This was largely due to news from a ...

AI Overviews drive 10% more queries for searches that show them. Search revenue grew 12% year-over-year. Google processes over 980 trillion tokens monthly. Google’s Q2 earnings show AI Overviews are ...

As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027. Recursion ...

Community driven content discussing all aspects of software development from DevOps to design patterns. The goal of Hibernate and JPA is to hide the complexity of SQL and relational databases from the ...

A Model Context Protocol (MCP) server that provides read-only MySQL database queries for AI assistants. Execute queries, explore database structures, and investigate your data directly from your ...

Executives from Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company, visit the Nasdaq MarketSite in Times Square on January 22 to ring the Nasdaq Opening Bell and celebrate the “Era of ...